ATR and breast cancer: Additionally, inhibition of RAD51 has been demonstrated to increase dependency on ATR-CHK1-mediated RSR signaling, and subsequent inhibition of ATR or CHK1 results in preferentially killing of HR-deficient breast cancer cells [135].